Yuval Cabilly

Insider Reports History

Location
C/O Biosight Therapeutics, 4 Hasadot Street, Ramat Hasharon, Israel
Signature
/s/ Roy Golan, as attorney-in-fact for the Reporting Person
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Yuval Cabilly:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Ayala Pharmaceuticals, Inc. Director Common Stock, par value $0.001 per share 677K $271K $0.40 Oct 18, 2023 Indirect

Insider Reports Filed by Yuval Cabilly

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ADXS Ayala Pharmaceuticals, Inc. Oct 18, 2023 0 $0 3 Nov 8, 2023 Director